Skip to main content

Maravai Lifesciences Holdings, Inc.

MRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001823239

No open-market purchases or sales by Maravai Lifesciences Holdings, Inc. insiders were filed in the last 90 days; 177 institutions reported holding it in 13F filings for Q2 2026, worth $875.5M in total; no superinvestor holds it.

Superinvestors holding MRVI, Q2 2026

See all superinvestors

No superinvestor reported holding MRVI in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of MRVI each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2023

    0 superinvestors holding at quarter end

    Sold out
    Maverick Capital
  2. Q1 2023

    1 superinvestor holding at quarter end

    New
    Maverick Capital
  3. Q4 2021

    0 superinvestors holding at quarter end

    Sold out
    D1 Capital Partners
  4. Q2 2021

    1 superinvestor holding at quarter end

    New
    D1 Capital Partners